These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36342716)

  • 21. Association of Days Alive and Out of the Hospital After Ventricular Assist Device Implantation With Adverse Events and Quality of Life.
    Noly PE; Wu X; Hou H; Grady KL; Stewart JW; Hawkins RB; Yang G; Kim KD; Zhang M; Cabrera L; Aaronson KD; Pagani FD; Likosky DS;
    JAMA Surg; 2023 Apr; 158(4):e228127. PubMed ID: 36811897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of insurance type on eligibility for advanced heart failure therapies and survival.
    Hutcheson SS; Phillips V; Patzer R; Smith A; Vega JD; Morris AA
    Clin Transplant; 2018 Aug; 32(8):e13328. PubMed ID: 29905971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal membrane oxygenation as a bridge to advanced heart failure therapies.
    Acharya D; Manandhar-Shrestha N; Leacche M; Rajapreyar I; William P; Kazui T; Hooker R; Tonna J; Jovinge S; Loyaga-Rendon R
    J Heart Lung Transplant; 2023 Aug; 42(8):1059-1071. PubMed ID: 36964083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.
    Nakagawa S; Garan AR; Takayama H; Takeda K; Topkara VK; Yuzefpolskaya M; Lin SX; Colombo PC; Naka Y; Blinderman CD
    J Palliat Med; 2018 Sep; 21(9):1284-1289. PubMed ID: 29874117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival in patients with post-LVAD right ventricular failure: multi-state modelling with competing outcomes of heart transplant.
    Shad R; Fong R; Quach N; Bowles C; Kasinpila P; Li M; Callon K; Castro M; Guha A; Suarez EE; Lee S; Jovinge S; Boeve T; Shudo Y; Langlotz CP; Teuteberg J; Hiesinger W
    J Heart Lung Transplant; 2021 Aug; 40(8):778-785. PubMed ID: 34167863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Marginal Improvement in Survival Post-Heart Transplantation in Patients With Prior Left Ventricular Assist Device: A Temporal Analysis of United Network of Organ Sharing Registry.
    Pal N; Stansfield J; Mukhopadhyay N; Nelson M
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):392-400. PubMed ID: 31679997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis.
    Cowger JA; Stulak JM; Shah P; Dardas TF; Pagani FD; Dunlay SM; Maltais S; Aaronson KD; Singh R; Mokadam NA; Kirklin JK; Salerno CT
    JACC Heart Fail; 2017 Oct; 5(10):691-699. PubMed ID: 28888521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
    Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
    J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.
    Ambardekar AV; Kittleson MM; Palardy M; Mountis MM; Forde-McLean RC; DeVore AD; Pamboukian SV; Thibodeau JT; Teuteberg JJ; Cadaret L; Xie R; Taddei-Peters W; Naftel DC; Kirklin JK; Stevenson LW; Stewart GC
    J Heart Lung Transplant; 2019 Apr; 38(4):408-417. PubMed ID: 30948210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
    Wang X; Luke AA; Vader JM; Maddox TM; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006284. PubMed ID: 32394720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence?
    Brown CR; Khurshan F; Chen Z; Groeneveld PW; McCarthy F; Acker M; Rame JE; Desai N
    J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2315-2324.e4. PubMed ID: 30955956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in eligibility for advanced heart failure therapies.
    Steinberg RS; Nayak A; O'Connell C; Burford S; Pekarek A; Chesnut N; Cole RT; Gupta D; Laskar SR; Bhatt K; Burke M; Attia T; Smith A; Vega JD; Morris AA
    Clin Transplant; 2020 May; 34(5):e13839. PubMed ID: 32073188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical outcome in patients with end-stage heart failure who underwent continuous-flow left ventricular assist devices in a single center.
    Park Y; Kim D; Yang JH; Cho YH; Choi JO; Jeon ES
    Korean J Intern Med; 2022 Mar; 37(2):340-349. PubMed ID: 34871480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left ventricular assist device bridging to heart transplantation: Comparison of temporary versus durable support.
    Hess NR; Hickey GW; Keebler ME; Huston JH; McNamara DM; Mathier MA; Wang Y; Kaczorowski DJ
    J Heart Lung Transplant; 2023 Jan; 42(1):76-86. PubMed ID: 36182653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.